Sign in
Explore the registryTrack Telisotuzumab vedotin's trials

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

Telisotuzumab vedotinOngoingActive not recruitingPhase 2Open NCT03539536 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…